Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Complete and partial molar pregnancy
Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending
!
Stabilise bleeding before diagnostic refinement
Heavy vaginal bleeding, haemodynamic compromise, respiratory symptoms, severe hypertension, neurological disturbance or clinically important thyrotoxicosis in suspected molar pregnancy can deteriorate rapidly.
Action: Use an obstetric ABCDE approach, call senior gynaecology, anaesthetic and blood-bank support, obtain urgent bloods and crossmatch, treat the immediate complication, and coordinate uterine evacuation in an appropriate theatre setting.
Overview
Distinguish complete from partial hydatidiform mole, recognise dangerous complications, and arrange definitive histology, specialist registration and safe follow-up without delay.
Gestational trophoblastic disease begins in placental trophoblast. Hydatidiform mole is a premalignant form in which abnormal fertilisation produces disordered villous development and trophoblastic proliferation. Complete and partial moles differ genetically, morphologically and in their probability of persistent disease, yet either can initially resemble a missed or incomplete miscarriage. The diagnosis has emotional as well as oncological consequences: the pregnancy is not viable, tissue requires expert assessment, and follow-up continues after the physical recovery from evacuation.
Most complete moles arise when an empty ovum is fertilised and paternal genetic material duplicates, producing an androgenetic diploid conceptus. Embryonic development is absent. Villi become diffusely hydropic with circumferential trophoblastic proliferation, and p57 immunostaining is usually absent because the maternally expressed gene is missing. Partial moles commonly result from dispermic fertilisation of a normal ovum, giving diandric triploidy. Fetal or embryonic tissue can occur, villous change is patchy, and p57 is usually retained; morphology and genotyping resolve difficult cases.
Aetiology
01
Androgenetic diploidy
Most complete moles follow fertilisation of an ovum lacking functional maternal chromosomes, with duplication of one paternal haploid set or, less often, dispermy.
02
Diandric triploidy
Most partial moles arise when two sperm fertilise a normal ovum, leaving one maternal and two paternal chromosome sets and permitting abnormal fetal development.
03
Maternal risk pattern
Previous molar pregnancy and extremes of reproductive age increase risk, but most affected patients have neither feature and cannot be identified by history alone.
Pathophysiology
1
Villous hydropic change
Abnormal genomic balance disrupts placental villous maturation, producing swollen avascular or poorly vascularised villi that can coalesce into visible vesicles.
2
Trophoblast proliferation
Paternally weighted genomic expression promotes excessive trophoblastic growth, which is usually diffuse in complete mole and patchier in partial mole.
3
Hormone excess
Expanded trophoblast produces hCG, driving nausea, ovarian theca-lutein cysts and thyroid-receptor stimulation when concentrations become particularly high.
4
Persistent cell survival
Residual trophoblastic cells can remain invasive or proliferate after uterine evacuation, causing a plateauing or rising hCG signal and occasionally metastatic disease.
Clinical features and red flags
Complete mole pattern
A non-viable pregnancy without fetal tissue, diffuse multicystic placental change, very high hCG and an enlarged uterus supports complete mole but still requires histology.
Partial mole pattern
Fetal tissue or an abnormal gestational sac with a thick cystic placenta and less striking hCG can suggest partial mole, although appearances often mimic miscarriage.
Systemic hCG effects
Disproportionate vomiting, biochemical thyrotoxicosis, bilateral theca-lutein cysts or hypertension unusually early in gestation indicates substantial trophoblastic hormone activity.
Post-evacuation persistence
Bleeding that continues, hCG that plateaus or rises, or new respiratory and neurological symptoms after treatment should trigger specialist review for neoplasia.
Incidental pathology diagnosis
Some moles have no distinctive scan or clinical clue and are found only when routine miscarriage tissue is examined by an experienced pathologist.
Red flags requiring action
Tachycardia, hypotension, syncope, pallor or ongoing heavy bleeding suggests major haemorrhage and requires simultaneous resuscitation and urgent operative planning.
Severe headache, visual symptoms, marked hypertension or proteinuria before 20 weeks is unusual and should prompt assessment for molar pregnancy and end-organ complications.
Investigations
01Transvaginal ultrasoundFirst step
Why
Assess viability, placental architecture, uterine contents and adnexa in early pregnancy.
Interpretation and limitations
Diffuse cystic intrauterine tissue without a fetus favours complete mole; focal placental change with fetal tissue can indicate partial mole, but neither appearance is definitive.
02Quantitative serum hCG
Why
Measure trophoblastic activity before treatment and establish a surveillance baseline.
Interpretation and limitations
A value markedly above that expected for gestation strengthens suspicion and prompts complication assessment; normal-range values cannot exclude a partial or complete mole.
03Histopathological examination
Why
Confirm and classify evacuated gestational tissue using morphology and ancillary testing when needed.
Interpretation and limitations
Villous distribution, trophoblast pattern, p57 expression and ploidy or genotyping distinguish complete mole, partial mole and non-molar hydropic loss.
04Full blood count and group
Why
Quantify anaemia and prepare transfusion and rhesus-related care around evacuation.
Interpretation and limitations
Haemoglobin may underestimate very acute loss; observations, active bleeding and serial results determine resuscitation, while RhD management follows current gestation-specific policy.
05
Differential diagnosis
01
Hydropic non-molar miscarriage
Degenerating chorionic villi can become oedematous after ordinary pregnancy loss; morphology, p57 and genetic testing prevent an unnecessary surveillance label.
02
Multiple gestation
Twins can cause high hCG, hyperemesis and a uterus larger than dates, while ultrasound shows separate sacs or fetuses rather than diffuse abnormal villi.
03
Pregnancy dating error
Incorrect menstrual dates can explain uterine-size and hCG discordance, but cannot account for characteristic placental cystic change or abnormal histopathology.
04
Placental mesenchymal dysplasia
This rare placental disorder creates enlarged cystic villi with a fetus and can mimic partial mole, requiring specialist placental pathology and genetic interpretation.
Management
01Suspected moleStabilise and define the operative riskFirst stepUltrasound, hCG or clinical features raise concern for a hydatidiform mole.+
1Assess bleeding, observations, uterine size, respiratory and neurological symptoms, blood pressure and features of clinically important thyrotoxicosis.
2Obtain quantitative hCG, full blood count, blood group, renal and liver profiles and thyroid tests when indicated, with crossmatch proportional to bleeding risk.
3Ask senior gynaecology and anaesthesia to plan evacuation, explaining pregnancy loss, diagnostic uncertainty and the need for histology and later surveillance.
02Uterine treatmentEvacuate safely and preserve diagnostic tissueDefinitiveThe patient is prepared for definitive treatment of a suspected molar pregnancy.+
1
Complications
01
Major haemorrhage
A vascular enlarged uterus and incomplete separation of abnormal tissue can produce severe bleeding during presentation, evacuation or persistent uterine disease.
02
Thyrotoxic crisis
Very high hCG can drive clinically important thyrotoxicosis, with peri-operative stress occasionally precipitating arrhythmia, cardiac failure or thyroid storm.
03
Gestational trophoblastic neoplasia
Persistent invasive mole or choriocarcinoma is signalled most often by an abnormal hCG trajectory and is more frequent after complete mole.
04
Psychological morbidity
Pregnancy loss combined with cancer surveillance, delayed conception and uncertain results can cause substantial distress that warrants proactive, individualised support.
Monitoring and follow-up
Record the pre-evacuation hCG, evacuation date and histological type because these determine interpretation and duration of specialist follow-up.
Track every requested blood or urine sample to a result; actively contact a patient who misses surveillance and address transport, language, privacy or practical barriers.
Defer a new pregnancy until the screening centre confirms completion, since pregnancy-related hCG obscures biochemical relapse and forces diagnostic uncertainty.
Review ongoing bleeding, infection symptoms, anaemia and emotional wellbeing after evacuation rather than treating surveillance as a laboratory-only process.
Arrange early assessment in a subsequent pregnancy and follow the centre's advice about post-pregnancy hCG or histological examination of placental tissue.
Special situations
p57 reflects parental origin
Absent p57 staining supports an androgenetic complete mole, whereas partial mole and non-molar gestations usually retain maternally expressed p57.
Ultrasound sensitivity is limited
Early complete moles and many partial moles lack the classic vesicular appearance, so tissue histology remains central after pregnancy loss.
Hysterectomy does not end follow-up
Removing the uterus reduces local tissue but cannot exclude occult extrauterine trophoblast; serial hCG remains mandatory after a confirmed mole.
Future prognosis is favourable
Most moles resolve after evacuation, chemotherapy is highly effective when required, and later fertility outcomes are generally reassuring after surveillance ends.
A second evacuation is specialist business
Benefit falls as hCG and disease burden increase, while perforation and haemorrhage remain possible, so the national centre should guide any repeat procedure.
Common pitfalls
01
Diagnosing a complete or partial mole from ultrasound alone and omitting histological confirmation.
02
Assuming fetal tissue excludes molar pregnancy when partial mole can include embryonic or fetal structures.
03
Forgetting thyroid, respiratory and hypertensive complications when hCG is very high.
04
Discharging after one negative local pregnancy test without specialist-centre registration and confirmation.
05
Performing repeated uterine evacuation for persistent hCG without discussion with the trophoblastic service.
06
Telling a patient to avoid pregnancy without offering acceptable contraception, a clear endpoint and emotional support.
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
Obstetrics and gynaecologyOriginal SBA
Definitive classification of suspected mole
A patient undergoes evacuation after ultrasound shows a non-viable pregnancy with cystic placental tissue and a high serum hCG. Which investigation definitively classifies complete or partial molar pregnancy?
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources
Sources and review status
National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.
Presentation has shifted with early pregnancy scanning. Vaginal bleeding remains common, but the historic combination of dramatic uterine enlargement, ovarian theca-lutein cysts, hyperemesis, pre-eclampsia before 20 weeks and thyrotoxicosis is now less frequent. A complete mole may show a heterogeneous intrauterine mass with many small cystic spaces and no fetus. Partial mole may show a growth-restricted or non-viable fetus, abnormal placenta and an enlarged cystic placenta, but ultrasound sensitivity is imperfect and a routine miscarriage can be reclassified only after histology.
Serum hCG is often disproportionately high in complete mole because abundant trophoblast produces hormone, but a value appropriate for gestation does not exclude either type. hCG also binds thyroid-stimulating hormone receptors, explaining gestational thyrotoxicosis when concentrations are very high. Assess haemoglobin, blood group, renal and liver function, thyroid function when symptomatic, blood pressure and urine protein. Review respiratory or neurological symptoms rather than attributing every complaint to early pregnancy, and involve anaesthesia early when severe systemic features increase peri-operative risk.
Definitive uterine management is planned with senior gynaecology. Suction evacuation is generally recommended for molar pregnancy when fertility preservation is desired. Prepare for haemorrhage, send tissue for histopathology and avoid relying on macroscopic vesicles alone. Hysterectomy can be considered for selected patients who do not wish to preserve fertility, but it does not remove the possibility of extrauterine trophoblast and does not eliminate hCG surveillance. Repeat evacuation for persistent disease is not routine and should be discussed with the treating trophoblastic centre.
The local team must register a confirmed case with a UK specialist screening service. Serial serum and urine hCG identifies spontaneous resolution or a plateau and rise requiring assessment for gestational trophoblastic neoplasia. Current follow-up duration depends on histological type, the time to hCG normalisation and the protocol of the responsible centre; partial moles usually need normalisation plus a confirmatory sample, while complete-mole follow-up can be longer when normalisation is delayed. Give the patient the centre's exact sample timetable rather than a generic calendar.
Discuss loss, uncertainty and fertility in direct, non-stigmatising language. Most patients need no chemotherapy and future fertility is usually preserved. Explain why pregnancy should be deferred until the centre formally ends surveillance, offer contraception that suits the patient, and arrange early ultrasound in a future pregnancy. Any later pregnancy event should be communicated to the centre if requested, and placental or pregnancy tissue should be examined where the specialist plan advises.
Key points
A complete mole usually has androgenetic diploidy, no embryo or fetus, diffuse hydropic villi and diffuse trophoblastic proliferation; a partial mole is commonly diandric triploid with focal villous change and may contain fetal tissue.
Vaginal bleeding is the common presentation, while excessive nausea, a uterus larger than dates, early-onset hypertension or clinical thyrotoxicosis are useful but increasingly uncommon clues after early ultrasound.
Ultrasound and serum hCG can raise suspicion but cannot reliably classify every case; histopathological examination of evacuated tissue establishes the diagnosis and may require p57 or genotyping support.
Suction evacuation is generally used for a suspected complete or partial mole when uterine preservation is intended, with senior planning for haemorrhage and anaesthetic risks.
Send all tissue for histology and clearly state the clinical and ultrasound suspicion so pathology can distinguish mole from non-molar hydropic miscarriage.
Register every histologically confirmed molar pregnancy with the appropriate UK trophoblastic screening centre; local negative pregnancy testing is not a substitute for central hCG surveillance.
The risk of persistent disease is greater after complete than partial mole, but neither type can be discharged without the centre-defined confirmation schedule.
Dyspnoea, chest pain, hypoxia or haemoptysis may reflect trophoblastic embolisation, pulmonary oedema, anaemia or metastatic gestational trophoblastic neoplasia and needs urgent escalation.
Agitation, fever, tremor, heart failure or arrhythmia with biochemical thyrotoxicosis raises concern for thyroid storm, particularly around evacuation.
Persistent or rising hCG, recurrent bleeding or new systemic symptoms after evacuation may indicate gestational trophoblastic neoplasia and must reach the specialist centre promptly.
Thyroid, renal and liver tests
Why
Identify hormone-mediated thyrotoxicosis and organ dysfunction that changes anaesthetic planning.
Interpretation and limitations
Suppressed TSH with raised free hormones may be hCG-mediated; severe symptoms need urgent specialist treatment rather than waiting for hCG to fall after evacuation.
06Blood pressure and urine protein
Why
Detect unusually early hypertensive disease associated with extensive molar tissue.
Interpretation and limitations
Hypertension or proteinuria before 20 weeks warrants urgent senior assessment and consideration of molar pregnancy alongside other rare causes.
Use suction evacuation in an appropriately staffed theatre when uterine preservation is intended, with haemorrhage equipment and blood support immediately available.
2Send all products for histopathology with gestation, imaging and suspected mole stated clearly; do not discard tissue after an apparently ordinary miscarriage.
3Treat haemorrhage and rhesus requirements according to current guidance, document the procedure and arrange review of the final pathology result.
03Confirmed diagnosisRegister and begin central surveillanceHistology reports a complete or partial hydatidiform mole.+
1Notify the appropriate regional trophoblastic screening centre promptly and supply the pathology, evacuation date, pre-treatment hCG and relevant clinical details.
2ConfirmatoryFollow the centre's serum and urine sampling instructions until normalisation and the required confirmatory period are formally complete.
3EscalationProvide written escalation symptoms, contraception advice and a named contact, and confirm that both patient and primary-care team understand who tracks every result.
04Abnormal follow-upEscalate possible neoplasiaEscalationSurveillance hCG rises, plateaus or remains abnormal, or concerning bleeding and systemic symptoms develop.+
1Contact the trophoblastic centre rather than arranging unsupervised repeat curettage or interpreting a single local assay in isolation.
2Assess haemodynamic stability and symptoms of uterine, pulmonary, hepatic or neurological disease, admitting urgently when bleeding or organ compromise is possible.
3Support specialist staging and risk scoring, then coordinate chemotherapy or selected surgery through the national treatment service.
Advise avoiding a new pregnancy until surveillance is complete because pregnancy raises hCG and prevents reliable detection of persistent trophoblast; discuss acceptable contraception and future-pregnancy support.